Skip to content

Neural Basis of Positive Response to Real-World Acupuncture Treatment for Migraine: A Multimodal Prospective Study Integrating fMRI and EEG

Neural Basis of Positive Response to Real-World Acupuncture Treatment for Migraine: A Multimodal Prospective Study Integrating fMRI and EEG

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2026001629
Enrollment
Unknown
Registered
2026-06-29
Start date
2026-06-30
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine

Interventions

Acupuncture group:Acupuncture

Sponsors

Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria (1) Fulfills the diagnostic criteria for migraine without aura according to the International Classification of Headache Disorders, 3rd edition (ICHD-3) , and meets the TCM diagnostic criteria (with reference to the 2017 edition of the Criteria for Diagnosis and Therapeutic Effect of TCM Diseases and Syndromes). (2) Aged 18–65 years, right-handed. (3) History of migraine with a frequency of =2 attacks per month and =2 attacks per week within the past 3 months. (4) Has not received prophylactic medication for migraine, or has completed a washout period of =4 weeks. (5) Voluntarily participates in the study and provides written informed consent.

Exclusion criteria

Exclusion criteria: (1) Patients with other types of headache or secondary headache attributed to epilepsy, cerebrovascular disease, or intracranial space-occupying lesions. (2) Patients with a history of severe cardiac, hepatic, or renal disease, or psychiatric disorders. (3) Patients with a history of craniocerebral surgery, non-MRI-compatible metallic implants, severe claustrophobia, or any other condition that precludes completion of cranial MRI examination. (4) Pregnant or lactating women. (5) Patients who have participated in other clinical studies within the recent period (e.g., within 3 months or 1 month). (6) Any other conditions that the investigator deems unsuitable for enrollment.

Design outcomes

Primary

MeasureTime frame
Responder rate (=50% reduction in MMD from baseline);

Secondary

MeasureTime frame
Change headache pain intensity;Migraine attack frequency;Headache duration;Acute medication use;Migraine-related disability;Overall impact of headache on functional health;Migraine-specific quality of life;Migraine-related functional impairment;Depression severity;Anxiety severity;Sleep quality;Traditional Chinese Medicine symptom improvement;Patient satisfaction;Electroencephalography power spectrum changes; Event-Related Potentials (ERPs);Electroencephalography microstate parameter changes;Brain morphological changes ;Changes in white matter microstructural integrity;Cerebral blood flow changes;Resting-state brain activity and functional connectivity changes;

Countries

China

Contacts

Public ContactGuangjun Wang

Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences

tjuwgj@gmail.com01064089386

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Aug 10, 2026